Carlos Pereira-Fernandez

Ingeniero Otamendi, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Systemic Use of Oral Rapamycin, Prednisone and Colchicine After Coronary Bare-Metal Stent Implantation: Narrative Review of Randomized Clinical Trials.

Systemic Use of Oral Rapamycin, Prednisone and Colchicine After Coronary Bare-Metal Stent Implantation: Narrative Review of Randomized Clinical Trials.

Journal: Biomedicines

Published: April 24, 2026

Computed Tomography Angiography or Standard Care After Left Main PCI?

Computed Tomography Angiography or Standard Care After Left Main PCI?

Journal: Journal of the American College of Cardiology

Published: June 16, 2025

Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) Trial.

Randomized Clinical Trial Comparing Bare-Metal Stents Plus Colchicine Versus Drug-Eluting Stents for Preventing Adverse Cardiac Outcomes: Three-Year Follow-Up Results of the ORal Colchicine in Argentina (ORCA) Trial.

Journal: Journal of clinical medicine

Published: March 30, 2025

Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysis.

Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysis.

Journal: Panminerva medica

Published: November 07, 2024

Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".

Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".

Journal: Circulation

Published: March 11, 2024

Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium.

Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium.

Journal: Frontiers in cardiovascular medicine

Published: August 10, 2023

Adjudicating Causes of Death in Revascularization Randomized Clinical Trials.

Adjudicating Causes of Death in Revascularization Randomized Clinical Trials.

Journal: JACC. Cardiovascular interventions

Published: May 21, 2023

High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data.

High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data.

Journal: Diagnostics (Basel, Switzerland)

Published: February 28, 2023

Is non-cardiac death increased with an initial invasive revascularization strategy? Commentary on the ISCHEMIA trial.

Is non-cardiac death increased with an initial invasive revascularization strategy? Commentary on the ISCHEMIA trial.

Journal: European heart journal open

Published: February 09, 2022

Drug-Eluting vs Bare-Metal Stents for Percutaneous Coronary Intervention.

Drug-Eluting vs Bare-Metal Stents for Percutaneous Coronary Intervention.

Journal: JAMA internal medicine

Published: March 15, 2021

Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention.

Randomized comparison between bare-metal stent plus colchicine versus drug-eluting stent alone in prevention of clinical adverse events after percutaneous coronary intervention.

Journal: Future cardiology

Published: November 11, 2020

Increased incidence of serious late adverse events with drug-eluting stents when compared with coronary artery bypass surgery: a cause of concern.

Increased incidence of serious late adverse events with drug-eluting stents when compared with coronary artery bypass surgery: a cause of concern.

Journal: Future cardiology

Published: July 10, 2020

Showing 1-12 of 27

Last Updated: 09/26/2026